American Heart Journal
Volume 157, Issue 3 , Pages 563-568, March 2009

Adverse association between diabetic retinopathy and cardiac structure and function

  • David Aguilar, MD

      Affiliations

    • Winters Center for Heart Failure Research and Section of Cardiology, Baylor College of Medicine, Houston, TX
    • Corresponding Author InformationReprint requests: David Aguilar, MD, Cardiovascular Division; Baylor College of Medicine, 1709 Dryden Street, Suite 9.39, MS: BCM 620, Houston, TX 77030.
  • ,
  • D. Michael Hallman, PhD

      Affiliations

    • Human Genetics Center, the University of Texas Health Science Center School of Public Health, Houston, TX
  • ,
  • Linda B. Piller, MD, MPH

      Affiliations

    • Human Genetics Center, the University of Texas Health Science Center School of Public Health, Houston, TX
  • ,
  • Barbara E.K. Klein, MD

      Affiliations

    • University of Wisconsin School of Medicine and Public Health, Madison, WI
  • ,
  • Ronald Klein, MD, MPH

      Affiliations

    • University of Wisconsin School of Medicine and Public Health, Madison, WI
  • ,
  • Richard B. Devereux, MD

      Affiliations

    • Weill Cornell Medical College, New York, NY
  • ,
  • Donna K. Arnett, PhD

      Affiliations

    • University of Alabama at Birmingham, AL
  • ,
  • Victor H. Gonzalez, MD

      Affiliations

    • Valley Retina Institute, McAllen, TX
  • ,
  • Craig L. Hanis, PhD

      Affiliations

    • Human Genetics Center, the University of Texas Health Science Center School of Public Health, Houston, TX

Received 6 August 2008; accepted 26 October 2008. published online 22 December 2008.

Background

Recent work has demonstrated a link between retinopathy, a marker of microvascular disease, and the development of heart failure, a finding particularly relevant in individuals with diabetes. Our objective was to assess the relationship between retinopathy and cardiac structure and function in a cohort of individuals with type 2 diabetes mellitus.

Methods

Stereoscopic fundus photography of 7 standard fields was obtained in 531 Mexican American adults with type 2 diabetes mellitus recruited as sibships from Starr County, Texas. Retinopathy was centrally scored and classified as no retinopathy, early nonproliferative diabetic retinopathy, moderate to severe nonproliferative diabetic retinopathy, or proliferative diabetic retinopathy. Echocardiography was used to assess cardiac structure and function. Multilevel mixed models were used to assess associations of clinical and echocardiographic variables with retinopathy while accounting for correlations among siblings.

Results

More severe diabetic retinopathy was associated with the presence of hypertension, previous cardiovascular disease, longer duration of diabetes, elevated glycosylated hemoglobin, and greater albuminuria. With worsening severity of diabetic retinopathy, left ventricular (LV) mass and left atrial dimension increased, and LV ejection fraction and LV fractional shortening decreased, independent of potential confounding variables.

Conclusions

More severe diabetic retinopathy was associated with worse cardiac structure and function by echocardiography independent of potential confounding variables. These data suggest a possible microvascular contribution to the development of diabetes-associated cardiac enlargement and dysfunction. Alternatively, common pathways may be leading to both disorders.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This study was supported in part by the National Heart, Lung, and Blood Institute Family Blood Pressure Program (HL54504), the National Eye Institute (EY12386), and an NIH Mentored Clinical Investigator Award (5K12RR017665-05) to Dr Aguilar.

PII: S0002-8703(08)00910-1

doi:10.1016/j.ahj.2008.10.019

American Heart Journal
Volume 157, Issue 3 , Pages 563-568, March 2009